Detail

Basic Information

GTO ID GTD0344
Accession E-MTAB-11315
Gene therapy-related clinical trial GTC2404
Altered gene S
Gene xrefs Gene ID: 1489668
Treatment ARCT-021(ARCT COVID-19 vaccine)
Control
Click to open

ARCT.101.5104.Day36_09;ARCT.101.5108.Day36_01;ARCT.101.5109.Day36_02;ARCT.101.5116.Day36_07;ARCT.101.6103.Day36_01;ARCT.101.6108.Day36_04;ARCT.101.6110.Day36_10;ARCT.101.6111.Day36_01;ARCT.101.7103.Day36_11;ARCT.101.7105.Day36_01;ARCT.101.7108.Day36_04;ARCT.101.7115.Day36_11;ARCT.101.8105.Day36_05;ARCT.101.8106.Day36_08;ARCT.101.8109.Day36_05;ARCT.101.8112.Day36_02

Case
Click to open

ARCT.101.6101.Day36_07;ARCT.101.6102.Day36_10;ARCT.101.6104.Day36_04;ARCT.101.6105.Day36_07;ARCT.101.6106.Day36_10;ARCT.101.6107.Day36_01;ARCT.101.6109.Day36_07;ARCT.101.6112.Day36_04;ARCT.101.6113.Day36_07;ARCT.101.6114.Day36_10;ARCT.101.6115.Day36_01;ARCT.101.6116.Day36_04;ARCT.101.8101.Day36_05;ARCT.101.8102.Day36_08;ARCT.101.8103.Day36_11;ARCT.101.8104.Day36_02;ARCT.101.8107.Day36_11;ARCT.101.8108.Day36_02;ARCT.101.8110.Day36_08;ARCT.101.8111.Day36_11;ARCT.101.8113.Day36_05;ARCT.101.8114.Day36_12;ARCT.101.8115.Day36_03;ARCT.101.8116.Day36_06

Disease COVID-19
Disease information Disease group: Infection
Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.
Xref: DO:0080600
Organism Homo sapiens
Tissue/Cell type blood
Characteristics Day36;3 microgram
Strategy Microarray
Platform A-MTAB-668

Differential genes

Volcano plot

−1−0.500.510123456
Down(5)Not Sig(560)Log2FC-Log10(adjusted P-value)-0.560.561.3

Heatmap

ARCT.101.5104.Day36_09ARCT.101.5108.Day36_01ARCT.101.5109.Day36_02ARCT.101.5116.Day36_07ARCT.101.6103.Day36_01ARCT.101.6108.Day36_04ARCT.101.6110.Day36_10ARCT.101.6111.Day36_01ARCT.101.7103.Day36_11ARCT.101.7105.Day36_01ARCT.101.7108.Day36_04ARCT.101.7115.Day36_11ARCT.101.8105.Day36_05ARCT.101.8106.Day36_08ARCT.101.8109.Day36_05ARCT.101.8112.Day36_02ARCT.101.6101.Day36_07ARCT.101.6102.Day36_10ARCT.101.6104.Day36_04ARCT.101.6105.Day36_07ARCT.101.6106.Day36_10ARCT.101.6107.Day36_01ARCT.101.6109.Day36_07ARCT.101.6112.Day36_04ARCT.101.6113.Day36_07ARCT.101.6114.Day36_10ARCT.101.6115.Day36_01ARCT.101.6116.Day36_04ARCT.101.8101.Day36_05ARCT.101.8102.Day36_08ARCT.101.8103.Day36_11ARCT.101.8104.Day36_02ARCT.101.8107.Day36_11ARCT.101.8108.Day36_02ARCT.101.8110.Day36_08ARCT.101.8111.Day36_11ARCT.101.8113.Day36_05ARCT.101.8114.Day36_12ARCT.101.8115.Day36_03ARCT.101.8116.Day36_06
−3−2−1012Z-Score

Enriched regulations/functions/pathways


Not Available


3.43.63.844.24.44.6cytokine production involved in immune responseregulation of cytokine production involved in immune responsetumor necrosis factor-mediated signaling pathwayregulation of type I interferon productiontype I interferon productionregulation of defense response to virusnegative regulation of I-kappaB kinase/NF-kappaB signalingmyeloid leukocyte cytokine productionregulation of defense response to virus by hostpositive regulation of defense response to virus by host
-Log10(P-value)

Differential cell type markers

Not Available